DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising breakthroughs throughout numerous clinical and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA gives a safer, extra trusted substitute for therapeutic use, not